Back to results
US 2022/0081432 A1Published application
Prostaglandin E Synthase Inhibitors and Methods for Utilizing the Same
AssigneeUniversity of Kentucky Research Foundation
InventorsChang-Guo Zhan, Fang Zheng, Kai Ding, Ziyuan Zhou
Life of this patent
Estimating the term…
Abstract
Compounds and compositions are provided that can inhibit microsomal prostaglandin E synthase-1 (mPGES-1). The compounds and compositions can reduce inflammation in a subject, such as inflammation caused by an inflammation disorder or symptoms thereof. Pharmaceutical compositions comprising the compound are also provided. Furthermore, methods are provided for reducing inflammation and/or inhibiting mPGES-1. The methods can comprise administering an effective amount of the composition to a subject.
Claims12
A compound of the formula:
- (a)
- or pharmaceutically acceptable salts thereof,
- wherein R1 is selected from the group consisting of H, an alkyl, an alkyl halide, an ether, and a carboxylic acid;
- wherein R2 is selected from the group consisting of H, a halide, an alkyne, and an aromatic;
- and
- wherein R3 is selected from the group consisting of H, a carboxyl, a carboxylic acid, and an alkyl;
- or
- (b)
- or pharmaceutically acceptable salts thereof;
- wherein R is selected from the group consisting of an aliphatic side chain and an alkyl;
- wherein X is selected from the group consisting of H, NO2, Br, and OMe;
- and
- wherein R′ and R″ are independently selected from the group consisting of CN, COOH, COOEt, CONH2, and NO2.
10 more elements
Dependencies are inferred from the claim text.